July 30 (Reuters) – Michigan reported 10,386 cases linked to an outbreak of cyclosporiasis on Thursday, up 309 from its last update a day earlier. Cases of the intestinal infection have risen steadily across the U.S., with the outbreak resulting in 193 hospitalizations, according to the state health
NEW YORK (AP) — A Senate committee on Thursday advanced Dr. Erica Schwartz’s nomination to be director of the nation’s top public health agency, setting aside concerns that she will not stand up to political meddling. If confirmed by the full Senate, the 54-year-old would become the 22nd director of
PLYMOUTH, Mass. (AP) — The two police officers focused first on Lindsay Clancy drifting in and out of consciousness in the snow after jumping from her Massachusetts home’s second-floor window. Within minutes, they were racing into the basement after her then-husband screamed that all three of their
By Ahmed Aboulenein WASHINGTON, July 30 (Reuters) – The U.S. Senate health committee voted on Thursday to advance the nomination of President Donald Trump’s pick for CDC director Dr. Erica Schwartz, handing his administration a rare win after repeated failed attempts to fill top health posts. The Se
July 30 (Reuters) – Drugmaker Eli Lilly and privately held contract manufacturer Resilience will invest $750 million to expand pharmaceutical manufacturing capacity in the U.S. and strengthen the domestic medicine supply chain, Resilience said on Thursday. Global drugmakers have been ramping up U.S.
By Sahil Pandey July 30 (Reuters) – Laboratory operator Labcorp raised its annual profit forecast and posted better-than-expected second-quarter results on Thursday, as steady demand for diagnostic testing and growth in its drug-development services business boosted performance. Shares of the compan
By Christy Santhosh July 30 (Reuters) – Shares of Capricor Therapeutics fell 50% in morning trading on Thursday after the U.S. FDA’s panel of experts voted against the effectiveness data of its cell therapy for a heart condition related to Duchenne muscular dystrophy. Late on Wednesday, the panel vo
By Sriparna Roy July 30 (Reuters) – Teladoc shares fell more than 26% on Thursday, a day after the virtual healthcare provider trimmed its annual revenue forecast and flagged challenges at its mental health services unit BetterHelp. BetterHelp, Teladoc’s direct-to-consumer mental health business, ha
July 30 (Reuters) – Regeneron on Thursday beat Wall Street estimates for second-quarter revenue and profit, helped by strong demand for its eczema drug Dupixent and a high-dose version of its eye drug Eylea. Shares rose nearly 5% before the bell. Here are the details: • Global net sales of Dupixent,
July 30 (Reuters) – The UK Health Security Agency (UKHSA) said on Thursday it was seeing a sharp rise in cyclospora infections among travellers returning from Mexico and urged people to follow food and water hygiene measures while abroad. The agency said the parasite causes stomach illness, mainly t
July 30 (Reuters) – Pfizer said on Thursday its oral drug helped restore skin color in patients with a common form of vitiligo in two late-stage trials, paving the way for regulatory submissions seeking approval in the autoimmune skin disease. Here are the details: • The U.S. drugmaker was testing L
By Christy Santhosh July 30 (Reuters) – Baxter International on Thursday raised its annual profit forecast and beat Wall Street estimates for quarterly results, helped by strong sales in its drug-compounding business, sending its shares soaring 17% in morning trading. The medical products maker is i
It’s been a choppy year for restaurants that lean into lettuce. Lettuce prices rose sharply in the first half of 2026 due to hot weather in Arizona, where about one-third of America’s lettuce is grown. Now, restaurants are dealing with the fallout from a cyclospora outbreak linked to shredded lettuc
July 30 (Reuters) – British consumer health company Haleon on Thursday reported stronger-than-expected sales growth in North America, its largest market, and robust demand in emerging markets, helping it reaffirm its financial targets. The maker of Sensodyne toothpaste and Advil painkillers has been
By Bhanvi Satija LONDON, July 30 (Reuters) – Sanofi raised its full-year sales forecast on Thursday, on the back of strong demand for blockbuster asthma drug Dupixent and newer products in the French drugmaker’s first results under new CEO Belen Garijo. Garijo has taken the helm at a time when the c
By Julie Steenhuysen CHICAGO, July 30 (Reuters) – Hilleman Laboratories, a Singapore-based joint venture between Merck and the global charity Wellcome, is gearing up to manufacture doses of a promising experimental vaccine against the rare Bundibugyo strain of Ebola responsible for a fast-spreading
By Ismail Shakil July 29 (Reuters) – The Trump administration said on Wednesday it will immediately release $600 million in congressionally appropriated funds for vaccines for the world’s poorest countries after Washington withheld the money over unsubstantiated safety concerns raised by U.S. Health
A diary played an unusual role in a contentious Senate hearing Wednesday – musings from Dr. Anthony Fauci, a scientist who became a leading voice in the U.S. response to the COVID-19 pandemic. Sen. Rand Paul, a Kentucky Republican, for years has accused Fauci, the longtime top infectious disease off
By Christy Santhosh and Sahil Pandey July 29 (Reuters) – The U.S. FDA’s panel of independent advisers on Wednesday voted against effectiveness data of Capricor Therapeutics’ cell therapy, deramiocel, for a heart condition related to Duchenne muscular dystrophy. The nine-to-three vote aligns with FDA
July 29 (Reuters) – Johnson & Johnson cut 2026 profit forecast on Wednesday, citing the combined financial impact of its newly completed acquisition of Firefly Bio and a strategic partnership with Sail Biomedicines. The healthcare giant expects full-year adjusted earnings per share of $10.96 to $11.
NEW YORK (AP) — A first-of-its-kind U.S. study suggests invasive mold infections may be an underappreciated — and potentially deadly — threat. The researchers detected about 450 cases in Atlanta-area hospitals over five years. About a third of the patients died in the hospital. The findings, publish
By Siddhi Mahatole July 29 (Reuters) – The U.S. FDA on Wednesday approved the first freeze-dried plasma product for use in the country, providing an option for patients when conventional plasma is unavailable. The agency granted a biologics license to Vascular Solutions — a subsidiary of Teleflex —
BUNIA, Congo (AP) — The fastest growing Ebola outbreak ever recorded is leaving thousands more people hungry in eastern Congo, a region engulfed in conflicts and a fight over precious minerals, the head of the U.N. food agency warned on Wednesday. The World Food Program’s acting executive director,
By Luciana Magalhaes SAO PAULO, July 29 (Reuters) – Brazil’s health regulator Anvisa on Wednesday said it approved five new injectable GLP-1 drugs for diabetes and obesity treatment, capitalizing on a wave of expedited regulatory reviews following the expiration of Ozempic’s patent in the country in
July 29 (Reuters) – Michigan health officials reported 10,077 cases of cyclosporiasis on Wednesday, an increase of 397 cases since their last update a day earlier. An investigation by the U.S. Food and Drug Administration has linked the outbreak to iceberg lettuce served at Taco Bell restaurants sou
BOGOTA, Colombia (AP) — More than a month has passed since Venezuela’s devastating earthquakes, and the constant sound of heavy machinery still echoes through the hardest-hit neighborhoods of La Guaira on the northern coast. Dust from collapsed buildings hangs in the humid air. Garbage has piled up.
July 29 (Reuters) – Processa Pharmaceuticals said on Wednesday it acquired privately held Vidya Therapeutics in an all-stock deal, gaining access to its lead candidate being developed to target diseases involving the immune system. Shares of Processa, which also reported a share sale to raise about
By Puyaan Singh July 29 (Reuters) – GE HealthCare said on Wednesday it might sell its patient care segment, after beating Wall Street estimates on steady demand for its diagnostics and imaging devices as well as tariff refunds. Shares of the company, which had already provided some preliminary secon
By Siddhi Mahatole July 29 (Reuters) – Medical device maker Boston Scientific cut its annual profit forecast on Wednesday, citing slower growth for its Watchman heart device and tougher competition in its U.S. electrophysiology business. Shares were down nearly 3% in morning trade. The company’s upd
(This is an excerpt of the Health Rounds newsletter, where we present latest medical studies on Tuesdays and Thursdays) By Nancy Lapid July 29 (Reuters) – We also report on an experimental diagnostic approach that can detect tuberculosis exposure and infection at an earlier stage than current method
